Gary Bridger - 13 Jun 2023 Form 4 Insider Report for X4 Pharmaceuticals, Inc (XFOR)

Role: Director
Signature: /s/ Adam S. Mostafa, attorney-in-fact
Issuer symbol: XFOR
Transactions as of: 13 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 14 Jun 2023, 17:05:58 UTC
Previous filing: 27 Jun 2022
Next filing: 11 Jun 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	XFOR	Common Stock	Award	$0	+45,000	+675%	$0.000000	51,667	13 Jun 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer.

Content

Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer.